Latest News

 Filter by Provider

Shares of power management chips maker Monolithic Power Systems (NASDAQ:MPWR) jumped 12.2% in the afternoon session after the company posted strong second-quarter results that surpassed expectations and offered an optimistic forecast for the upcoming quarter. The power solutions company reported revenue of $664.6 million, a 31% increase from the previous year. This growth was fueled by strong demand across its various markets, with the Storage and Computing segment posting a remarkable 70% year-over-year jump. Looking ahead, the company projected third-quarter revenue between $710 million and $730 million, which exceeded analysts' predictions. This positive outlook prompted several investment firms, such as KeyBanc, to raise their price targets on the stock and signaled confidence in the company's continued performance.

Shares of household products company Kimberly-Clark (NYSE:KMB) jumped 4.8% in the afternoon session after the company reported mixed second-quarter results that featured the strongest sales volume growth in five years and an earnings-per-share figure that surpassed analyst expectations. Investors looked past a headline revenue figure that missed expectations, which the company attributed to recent business divestitures. Instead, market participants focused on a 3.9% rise in organic sales, a key metric that shows the health of the core business. This growth was fueled by the strongest increase in sales volume in five years, suggesting robust consumer demand. Furthermore, the company's adjusted earnings per share of $1.92 comfortably surpassed analyst forecasts. The strong underlying performance and profit beat signaled that the company's strategic plans found success.

Shares of precision measurement company Mettler-Toledo (NYSE:MTD) fell 5.1% in the afternoon session after investors focused on declining profitability and the future impact of new tariffs, even though the company's second-quarter results beat analyst expectations. While Mettler-Toledo posted higher sales and adjusted earnings that surpassed forecasts, its reported net income and earnings per share declined from the previous year. Investors appeared concerned by shrinking profit margins, as the company's gross margin fell. The company also pointed to newly announced tariffs on goods imported from Switzerland, which created uncertainty around future profits. These company-specific headwinds occurred amid a broader market downturn fueled by a weak jobs report and widespread trade fears.

Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 3.7% in the afternoon session after the company posted strong second-quarter earnings that beat expectations and raised its full-year financial forecast. The pharmaceutical giant disclosed adjusted earnings of $2.97 per share and revenues of $15.42 billion, both numbers surpassing analyst estimates. This performance was driven by robust sales from its immunology drugs, Rinvoq and Skyrizi, which successfully offset lower sales from the company's older drug, Humira. Confident in its momentum, AbbVie lifted its full-year guidance for both revenue and adjusted earnings per share. In response to the strong results, analysts at firms including Morgan Stanley and Raymond James increased their price targets on the stock.

Shares of fast food chain El Pollo Loco (NASDAQ:LOCO) jumped 4.7% in the morning session after the fast-food chain reported strong second-quarter results that surpassed analyst expectations for both revenue and profit. The company posted revenue of $125.8 million, driven by investments in its brand and successful menu innovations like new wraps and salads. Adjusted earnings reached $0.28 per share, beating consensus estimates. El Pollo Loco also highlighted significant growth in its digital channel, which accounted for more than a quarter of all sales. This outperformance occurred while the wider restaurant industry experienced softer demand, prompting analysts to grow more bullish on the company's outlook.

Shares of engineered materials manufacturer Rogers (NYSE:ROG) fell 3.7% in the afternoon session after the company reported disappointing second-quarter 2025 financial results, which included a significant net loss and a miss on earnings expectations. The company posted a net loss of $73.6 million, or $4.00 per share, for the quarter. This loss included $71.8 million in non-cash impairment charges and $4.3 million in restructuring costs, largely related to its AES curamik® business. While revenue grew from the previous quarter, adjusted earnings per share of $0.34 missed analyst forecasts. Furthermore, sales declined 5.3% compared to the same period last year, which reflected lower demand from the electric vehicle and wireless infrastructure markets.

Shares of medical device company ResMed (NYSE:RMD) jumped 3.1% in the afternoon session after the company reported strong fourth-quarter financial results that surpassed analyst estimates. 

Shares of biotech company Regeneron (NASDAQ:REGN) jumped 3.3% in the morning session after the company reported strong second-quarter financial results that significantly surpassed analyst expectations. The pharmaceutical giant posted earnings per share of $12.89, which crushed the forecast of $8.50. Revenue also beat projections, totaling $3.68 billion against an expected $3.29 billion. This performance marked a notable rebound from the prior quarter. The growth stemmed from strong sales of key treatments, including its eye care therapy Eylea HD, cancer drug Libtayo, and immunology medicine Dupixent, which all recorded substantial sales increases.

Shares of higher education company Perdoceo Education (NASDAQ:PRDO) jumped 3.2% in the afternoon session after the company reported strong second-quarter results that surpassed analyst expectations for both earnings and revenue. The education provider posted revenue of $209.6 million, a 25.7% increase from the previous year, driven by a 17.4% rise in total student enrollments. The company's adjusted earnings per share landed at $0.67 and surpassed the consensus estimate of $0.60. In a show of confidence, management boosted shareholder returns. The board authorized a new $75 million share buyback program and approved a 15.4% increase in the quarterly dividend. The company also provided an optimistic full-year forecast, which further bolstered investor sentiment.

Guggenheim analyst maintained Buy rating and $14 price forecast for Paramount Global, citing outperformance in DTC segment and strong content portfolio.

Shares of financial and compliance reporting software company Workiva (NYSE:WK) jumped 26.5% in the morning session after the company reported strong second-quarter financial results that beat Wall Street estimates and raised its full-year guidance. 

Shares of telecommunications infrastructure company Lumen Technologies (NYSE:LUMN) fell 18.5% in the morning session after the company reported second-quarter revenue that fell short of Wall Street estimates and declined from the previous year. The telecommunications firm posted revenue of $3.09 billion, just under the $3.11 billion analysts anticipated and down 5.4% from the same period last year. The shortfall hit both of its major divisions, with Business segment revenue decreasing 3.4% and its Mass Markets segment falling 12.8%. These results overshadowed some positive developments, including a smaller-than-expected adjusted loss and a substantial increase in the company's full-year free cash flow guidance. The weak report landed amid broader economic jitters after a disappointing U.S. jobs report fueled concerns of a slowdown, likely amplifying the negative investor reaction.

Shares of blockchain infrastructure company Coinbase (NASDAQ:COIN) fell 15.3% in the morning session after the company reported disappointing second-quarter financial results that fell short of Wall Street's expectations. 

Shares of life sciences company Avantor (NYSE:AVTR) fell 15.5% in the morning session after the company reported disappointing second-quarter results and cut its full-year financial forecast. The company’s adjusted earnings per share of $0.24 missed analyst expectations, while revenue slipped 1% to $1.68 billion. Profitability saw a sharp decline as net income fell to $64.7 million from $92.9 million in the same quarter of the previous year. The company's Laboratory Solutions division, a key revenue source, recorded a 3% drop in sales. Compounding these issues, Avantor lowered its financial projections for the full year, signaling to investors that it anticipated these headwinds would continue. The combination of missing current earnings and lowering future guidance prompted the negative investor reaction.

Shares of modular flooring manufacturer Interface (NASDAQ:TILE) jumped 19.1% in the morning session after the company reported strong second-quarter earnings that surpassed analyst expectations and raised its full-year forecast. The carpet tile maker announced adjusted earnings of $0.60 per share on revenue of approximately $376 million, which comfortably beat Wall Street's projections. This performance represented a significant 50% jump in adjusted earnings and an 8% increase in sales compared to the same quarter last year. Following the strong results, management lifted its financial guidance for the full year. The company credited its success to its "One Interface" strategy, which helped drive market share gains and expanded its gross profit margin.

Shares of manufacturing company Leggett & Platt (NYSE:LEG) fell 12% in the morning session after the company reported second-quarter results that showed a drop in sales and a weak forecast, with a broader market downturn adding to the negative sentiment. The furniture and bedding component maker's sales decreased by 6% from the prior year. While adjusted earnings per share ticked up slightly, the figure missed some analyst estimates. The company's outlook also concerned investors, as it expected a mid-teens volume decline in its Bedding Products segment. Leggett & Platt did maintain its full-year guidance, but that forecast still projected an annual sales drop. The negative report landed amidst a wider market sell-off, which was triggered by a weak U.S. jobs report and the announcement of new tariffs.

Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 18% in the morning session after the company reported strong second-quarter earnings that surpassed analyst expectations and raised its full-year revenue forecast. 

Shares of HR outsourcing provider Insperity (NYSE:NSP) fell 23.5% in the morning session after the company reported disappointing second-quarter financial results and issued a weak outlook for the rest of the year. The human resources firm posted adjusted earnings of $0.26 per share, a figure that missed analyst estimates and represented a 70% plunge from the prior year. The company attributed the significant drop in profit to higher-than-expected benefits costs, specifically pointing to rising pharmacy expenses and an increased frequency of large insurance claims. This surge in costs also caused the company's gross profit to fall by 14% compared to the same quarter last year. To cap off the disappointing report, Insperity lowered its full-year earnings forecast, signaling to investors that these challenges were expected to persist.

Shares of satellite communications company EchoStar (NASDAQGS:SATS) fell 16.7% in the morning session after the company reported second-quarter financial results that missed analyst expectations on both revenue and earnings. The company reported second-quarter revenue of $3.72 billion, which fell short of analyst forecasts and represented a 5.8% decline from the same period last year. EchoStar also posted a loss of $1.06 per share, missing Wall Street's expectations. This loss widened significantly from the $0.76 loss per share recorded in the prior year's quarter. The combination of missing on both revenue and earnings prompted a negative reaction from investors.

Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) jumped 11.9% in the morning session after the company reported strong second-quarter results that beat analyst expectations and raised its full-year financial forecast. The wellness products company announced its net sales grew 4% year-over-year to $114.8 million. Profits experienced a significant jump, as net income more than quadrupled to $5.3 million compared to the same period last year. The company's adjusted EBITDA, a key measure of profitability, also increased by 8%. Bolstered by this performance, Nature's Sunshine lifted its full-year revenue guidance to a range of $460 million to $475 million. Management credited strong sales in Japan and Central Europe, alongside accelerated growth in its digital business, for the robust quarter.

Shares of online community and discussion platform Reddit (NYSE:RDDT) jumped 22.1% in the morning session after the company posted record-breaking second-quarter revenue and provided a strong forecast for the upcoming quarter. The social media platform's revenue jumped 78% year-over-year to $500 million, soundly beating Wall Street's expectations. Earnings per share landed at $0.45, more than doubling the forecasted amount. The company's user base also expanded, with daily active users growing 21% to 110.4 million. This performance was fueled by an 84% surge in advertising revenue and growth from data licensing deals. Looking ahead, Reddit projected third-quarter revenue well above consensus estimates, prompting analysts at Morgan Stanley to raise their price target on the stock.

Shares of dental products company Envista Holdings (NYSE:NVST) jumped 8.2% in the morning session after the company reported second-quarter results that surpassed analyst estimates and raised its full-year financial outlook. The company posted revenue of $682 million and adjusted earnings per share of $0.26, both of which topped Wall Street's expectations. This performance stemmed from accelerated growth across its business segments, and its Specialty Products & Technologies division showed particular strength. In light of the strong results, Envista lifted its full-year guidance for 2025. The company increased its adjusted earnings per share outlook to a range of $1.05 to $1.15 and its core sales growth forecast to between 3% and 4%.

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper end of its 2025 revenue forecast, citing a delay in vaccine shipments. The company pointed to a delay in vaccine deliveries to the United Kingdom, which it pushed into the first quarter of 2026. This news overshadowed second-quarter results that beat Wall Street expectations. For the quarter, Moderna's revenue dropped about 41% from the previous year to $142 million, driven by lower sales of its COVID-19 vaccine. Despite the revenue decline, the company successfully narrowed its net loss as its cost-cutting measures took effect. Adding to the pressure, Moderna also announced plans to reduce its workforce by 10% and confirmed a delay in the U.S. approval for its combined COVID-flu vaccine until 2026.

Shares of real estate technology company eXp World (NASDAQ:EXPI) fell 15.4% in the morning session after the company reported disappointing second-quarter financial results, including a significant earnings miss and a net loss. 

Shares of outdoor lifestyle and equipment company Clarus (NASDAQ:CLAR) fell 10.9% in the morning session after the company reported disappointing second-quarter 2025 financial results, including a wider net loss and a drop in sales. 

Shares of outerwear manufacturer Columbia Sportswear (NASDAQ:COLM) fell 14.6% in the morning session after the company issued a disappointing financial forecast for its third quarter and the full year, which overshadowed a second-quarter earnings beat. 

Shares of semiconductor manufacturer Magnachip Semiconductor (NYSE:MX) fell 24.6% in the morning session after the company issued a weak financial outlook for the third quarter and lowered its full-year revenue forecast. 

Shares of online payroll and human resource software provider Asure (NASDAQ:ASUR) fell 14.1% in the morning session after the company reported second-quarter financial results that fell short of Wall Street's expectations for both revenue and profit. The payroll and HR software provider announced revenue of $30.1 million and a loss of $0.22 per share, both of which missed analyst estimates. The company’s adjusted EBITDA and its guidance for third-quarter adjusted EBITDA also came in below projections. Further clouding the outlook, bookings for the quarter declined 53% compared to the prior year. While Asure did raise its full-year revenue forecast, this positive note was overshadowed by the immediate shortfalls and a weaker profit outlook. The report landed amid broader market turmoil, as new global tariffs and a poor jobs report soured investor sentiment toward technology stocks.

Shares of professional consulting firm ICF International (NASDAQ:ICFI) jumped 9.1% in the afternoon session after it reported second-quarter results that showed stronger-than-expected profits, fueled by significant growth in its commercial energy business. Investors looked past a slight revenue miss, focusing instead on earnings per share of $1.66, which beat analyst forecasts. The company's commercial energy division delivered a remarkable 27% year-over-year revenue increase, offsetting challenges in the federal government sector. A strong book-to-bill ratio of 1.30 pointed to a healthy pipeline of future work. Management also reaffirmed its full-year guidance and signaled a return to growth in 2026, which further boosted investor sentiment.

Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.1% in the afternoon session as investors reacted to its second-quarter earnings report, where a year-over-year revenue decline overshadowed beats on profit and sales forecasts. The life sciences company reported that revenue fell 3% from the prior year, sparking concerns about its growth trajectory. Management pointed to challenges in the research market, citing uncertainty around National Institutes of Health (NIH) funding and ongoing export restrictions that limited sales in China. These company-specific issues were compounded by broader market fears over new tariffs and weak U.S. jobs data. While Illumina did raise its full-year profit guidance and announced the acquisition of SomaLogic, investors focused on the top-line revenue weakness.

Shares of cloud computing and online retail behemoth Amazon (NASDAQ:AMZN) fell 7.8% in the afternoon session after the company reported disappointing second-quarter results and provided a weak forecast for future growth. 

Fluor just found a solution to the "problem" of NuScale's incredibly successful stock.

Reddit is scoring AI wins, and the company's second-quarter report arrived with some great news for investors.

SpaceX used the Falcon 9 rocket with the Dragon capsule to send the four astronauts to the International Space Station for a six-month mission.

Meta Platforms, Microsoft, Apple and Amazon were key earnings.

Roblox Corp is experiencing a market shift, with strong Q2 results and raised price forecasts due to viral games and expanding reach.

Shares of lidar technology developer AEye are trading lower Friday morning. The company released its second-quarter 2025 financial results.